The high mutation frequency of TP53, APC, and KRAS in CORE and that of KRAS in PAAD were reported in multiple other studies (Vogelstein et al., 1988; Kinzler and Vogelstein, 1996; Bardeesy and DePinho, 2002). This evidence concerns the gene KRAS and pancreatic adenocarcinoma.